Table of Contents

1 Study Coverage

• 1.1 Ancillary Reagents Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Ancillary Reagents Market Size Growth Rate by Product
  • 1.4.2 Anticoagulants
  • 1.4.3 Buffered Solutions & Culture Media
  • 1.4.4 Cryoprotectants
  • 1.4.5 Cytokines
  • 1.4.6 Antibodies & Beads
  • 1.4.7 Enzymes
  • 1.4.8 Human or Bovine Serum
• 1.5 Market by End User
  • 1.5.1 Global Ancillary Reagents Market Size Growth Rate by End User
  • 1.5.2 Pharmaceutical Manufacturers
  • 1.5.3 Biotech Companies
  • 1.5.4 Research Organizations
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Ancillary Reagents Market Size
  • 2.1.1 Global Ancillary Reagents Revenue 2014-2025
  • 2.1.2 Global Ancillary Reagents Sales 2014-2025
• 2.2 Ancillary Reagents Growth Rate by Regions
  • 2.2.1 Global Ancillary Reagents Sales by Regions
  • 2.2.2 Global Ancillary Reagents Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Ancillary Reagents Sales by Manufacturers
  • 3.1.1 Ancillary Reagents Sales by Manufacturers
  • 3.1.2 Ancillary Reagents Sales Market Share by Manufacturers
  • 3.1.3 Global Ancillary Reagents Market Concentration Ratio (CR5 and HHI)
• 3.2 Ancillary Reagents Revenue by Manufacturers
  • 3.2.1 Ancillary Reagents Revenue by Manufacturers (2014-2019)
  • 3.2.2 Ancillary Reagents Revenue Share by Manufacturers (2014-2019)
• 3.3 Ancillary Reagents Price by Manufacturers
• 3.4 Ancillary Reagents Manufacturing Base Distribution, Product Types
  • 3.4.1 Ancillary Reagents Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Ancillary Reagents Product Type
  • 3.4.3 Date of International Manufacturers Enter into Ancillary Reagents Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Ancillary Reagents Sales by Product
• 4.2 Global Ancillary Reagents Revenue by Product
• 4.3 Ancillary Reagents Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Ancillary Reagents Breakdown Data by End User

6 North America

• 6.1 North America Ancillary Reagents by Countries
  • 6.1.1 North America Ancillary Reagents Sales by Countries
  • 6.1.2 North America Ancillary Reagents Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Ancillary Reagents by Product
• 6.3 North America Ancillary Reagents by End User

7 Europe

• 7.1 Europe Ancillary Reagents by Countries
  • 7.1.1 Europe Ancillary Reagents Sales by Countries
  • 7.1.2 Europe Ancillary Reagents Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Ancillary Reagents by Product
• 7.3 Europe Ancillary Reagents by End User

8 Asia Pacific

• 8.1 Asia Pacific Ancillary Reagents by Countries
  • 8.1.1 Asia Pacific Ancillary Reagents Sales by Countries
  • 8.1.2 Asia Pacific Ancillary Reagents Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Ancillary Reagents by Product
• 8.3 Asia Pacific Ancillary Reagents by End User

9 Central & South America

• 9.1 Central & South America Ancillary Reagents by Countries
  • 9.1.1 Central & South America Ancillary Reagents Sales by Countries
  • 9.1.2 Central & South America Ancillary Reagents Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Ancillary Reagents by Product
• 9.3 Central & South America Ancillary Reagents by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Ancillary Reagents by Countries
  • 10.1.1 Middle East and Africa Ancillary Reagents Sales by Countries
  • 10.1.2 Middle East and Africa Ancillary Reagents Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Ancillary Reagents by Product
• 10.3 Middle East and Africa Ancillary Reagents by End User

11 Company Profiles

• 11.1 Becton
  • 11.1.1 Becton Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Becton Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Becton Ancillary Reagents Products Offered
  • 11.1.5 Becton Recent Development
• 11.2 Dickinson and Company
  • 11.2.1 Dickinson and Company Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Dickinson and Company Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Dickinson and Company Ancillary Reagents Products Offered
  • 11.2.5 Dickinson and Company Recent Development
• 11.3 Sigma-Aldrich
  • 11.3.1 Sigma-Aldrich Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Sigma-Aldrich Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Sigma-Aldrich Ancillary Reagents Products Offered
  • 11.3.5 Sigma-Aldrich Recent Development
• 11.4 Beckman Coulter
  • 11.4.1 Beckman Coulter Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Beckman Coulter Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Beckman Coulter Ancillary Reagents Products Offered
  • 11.4.5 Beckman Coulter Recent Development
• 11.5 Genemed Biotechnologies
  • 11.5.1 Genemed Biotechnologies Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Genemed Biotechnologies Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Genemed Biotechnologies Ancillary Reagents Products Offered
  • 11.5.5 Genemed Biotechnologies Recent Development
• 11.6 Leica Biosystems
  • 11.6.1 Leica Biosystems Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Leica Biosystems Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Leica Biosystems Ancillary Reagents Products Offered
  • 11.6.5 Leica Biosystems Recent Development
• 11.7 Genetex
  • 11.7.1 Genetex Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Genetex Ancillary Reagents Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Genetex Ancillary Reagents Products Offered
  • 11.7.5 Genetex Recent Development

12 Future Forecast

• 12.1 Ancillary Reagents Market Forecast by Regions
  • 12.1.1 Global Ancillary Reagents Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Ancillary Reagents Revenue Forecast by Regions 2019-2025
• 12.2 Ancillary Reagents Market Forecast by Product
  • 12.2.1 Global Ancillary Reagents Sales Forecast by Product 2019-2025
  • 12.2.2 Global Ancillary Reagents Revenue Forecast by Product 2019-2025
• 12.3 Ancillary Reagents Market Forecast by End User
• 12.4 North America Ancillary Reagents Forecast
• 12.5 Europe Ancillary Reagents Forecast
• 12.6 Asia Pacific Ancillary Reagents Forecast
• 12.7 Central & South America Ancillary Reagents Forecast
• 12.8 Middle East and Africa Ancillary Reagents Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Ancillary Reagents Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Ancillary reagents are used during the manufacturing of cell therapy products, however, are not intended to be part of the final products. The ancillary reagents are used as a growth and survival promoter for certain cell populations and have profound effects on a cell product.  Ancillary reagents for cell based therapies include antibiotics, cytokines, growth factors, culture media, enzymes and serum derivatives. Ancillary reagents might affects the efficacy of cell based products, thus, quality assurance of ancillary reagents are critical for cell based products. The standers for ancillary reagents are developed by The US Pharmacopeia Convention (USP). On the other hand, there are no regulations specific for the ancillary reagents.
The growth ancillary reagents market is primarily driven by the growing manufacturing practices of cell based therapies, growing research and development activities for the development of cell and tissue based therapies there by increasing adoption of ancillary reagents.
There are still many challenges related to ancillary reagents in the development of cell-based therapeutics, such as extensive and expensive qualification activities, manufacturing reagents under GMP. Additional challenge includes, the development of analytical test methods and potency assays for ancillary reagents that are biological in nature to assist with key qualification activities assessing purity, identity, safety and even suitability. Some ancillary reagents are approved pharmaceutical products such as Heparin and insulin, are available as GMP-grade materials and often used in cell product manufacturing.
The global Ancillary Reagents market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ancillary Reagents market based on company, product type, end user and key regions.

This report studies the global market size of Ancillary Reagents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ancillary Reagents in these regions.
This research report categorizes the global Ancillary Reagents market by top players/brands, region, type and end user. This report also studies the global Ancillary Reagents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Becton
Dickinson and Company
Sigma-Aldrich
Beckman Coulter
Genemed Biotechnologies
Leica Biosystems
Genetex

Market size by Product
Anticoagulants
Buffered Solutions & Culture Media
Cryoprotectants
Cytokines
Antibodies & Beads
Enzymes
Human or Bovine Serum
Market size by End User
Pharmaceutical Manufacturers
Biotech Companies
Research Organizations

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Ancillary Reagents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ancillary Reagents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ancillary Reagents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ancillary Reagents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ancillary Reagents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ancillary Reagents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.